T. Philip, C. Guglielmi, A. Hagenbeek, R. Somers, H. Van-der-lelie et al., Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma, New England Journal of Medicine, vol.333, issue.23, pp.1540-1545, 1995.
DOI : 10.1056/NEJM199512073332305

M. Attal, J. L. Harousseau, A. M. Stoppa, J. J. Sotto, J. G. Fuzibet et al., A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma, New England Journal of Medicine, vol.335, issue.2, pp.91-97, 1996.
DOI : 10.1056/NEJM199607113350204

A. M. Gianni, S. Siena, M. Bregni, C. Tarella, A. C. Stern et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION, The Lancet, vol.334, issue.8663, pp.580-585, 1989.
DOI : 10.1016/S0140-6736(89)90711-3

S. Munshi, J. Singhal, S. Mehta, J. Tindle, D. Nelson et al., Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma, J Clin Oncol, vol.16, pp.1547-1553, 1998.

M. Dale, G. W. Dart, M. M. Roberts, and R. E. Sage, Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood, Exp Hematol, vol.18, pp.442-447, 1990.

L. Jahnke, S. Gordon, K. Newman, B. W. Byrd, N. Cooper et al., Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells, J Clin Oncol, vol.14, pp.277-286, 1996.

O. Connor, E. Berkman, J. K. Erban, K. A. Sprague, K. B. Miller et al., Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation, Blood, vol.98, pp.2059-2064, 2001.

O. N. Koc, S. L. Gerson, B. W. Cooper, M. Laughlin, H. Meyerson et al., Randomized Cross-Over Trial of Progenitor-Cell Mobilization: High-Dose Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor (G-CSF) Versus Granulocyte-Macrophage Colony-Stimulating Factor Plus G-CSF, Journal of Clinical Oncology, vol.18, issue.9, pp.1824-1830, 2000.
DOI : 10.1200/JCO.2000.18.9.1824

J. P. Levesque, Y. Takamatsu, S. K. Nilsson, D. N. Haylock, and P. J. Simmons, Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor, Blood, vol.98, issue.5, pp.1289-1297, 2001.
DOI : 10.1182/blood.V98.5.1289

J. P. Levesque, J. Hendy, Y. Takamatsu, B. Williams, I. G. Winkler et al., Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment, Experimental Hematology, vol.30, issue.5, pp.440-449, 2002.
DOI : 10.1016/S0301-472X(02)00788-9

K. Theilgaard-monch, K. Raaschou-jensen, H. Palm, K. Schjodt, C. Heilmann et al., Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts, Bone Marrow Transplantation, vol.28, issue.11, pp.1073-1082, 2001.
DOI : 10.1038/sj.bmt.1703270

H. Tayebi, F. Kuttler, P. Saas, A. Lienard, B. Petracca et al., Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells, Experimental Hematology, vol.29, issue.4, pp.458-470, 2001.
DOI : 10.1016/S0301-472X(01)00613-0

S. Rutella, L. Pierelli, G. Bonanno, S. Sica, F. Ameglio et al., Role for granulocyte colonystimulating factor in the generation of human T regulatory type 1 cells Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients, Blood. Exp Hematol, vol.100, issue.28, pp.2562-2571, 2000.

E. M. Sloand, S. Kim, J. P. Maciejewski, F. Van-rhee, A. Chaudhuri et al., Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo, Blood, vol.95, pp.2269-2274, 2000.

G. Schiavoni, F. Mattei, T. Di-pucchio, S. M. Santini, L. Bracci et al., Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer, Blood, vol.95, pp.2024-2030, 2000.

M. Awwad and R. J. North, Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden, Immunology, vol.65, pp.87-92, 1988.

F. Ghiringhelli, N. Larmonier, E. Schmitt, A. Parcellier, D. Cathelin et al., CD4+CD25+ regulatory T???cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative, European Journal of Immunology, vol.34, issue.2, pp.336-344, 2004.
DOI : 10.1002/eji.200324181

M. J. Turk, J. A. Guevara-patino, G. A. Rizzuto, M. E. Engelhorn, and A. N. Houghton, Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells, The Journal of Experimental Medicine, vol.59, issue.6, pp.771-782, 2004.
DOI : 10.1038/nature01152

O. Garra, A. , and P. Vieira, Regulatory T cells and mechanisms of immune system control, Nature Medicine, vol.155, issue.8, pp.801-805, 2004.
DOI : 10.1084/JEM.20011288

C. A. Piccirillo and A. M. Thornton, Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells, Trends in Immunology, vol.25, issue.7, pp.374-380, 2004.
DOI : 10.1016/j.it.2004.04.009

H. Yagi, T. Nomura, K. Nakamura, S. Yamazaki, T. Kitawaki et al., Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells, International Immunology, vol.16, issue.11, pp.1643-1656, 2004.
DOI : 10.1093/intimm/dxh165

R. S. Mchugh, M. J. Whitters, C. A. Piccirillo, D. A. Young, E. M. Shevach et al., CD4+CD25+ Immunoregulatory T Cells, Immunity, vol.16, issue.2, pp.311-323, 2002.
DOI : 10.1016/S1074-7613(02)00280-7

B. Birebent, R. Lorho, H. Lechartier, S. De-guibert, M. Alizadeh et al., Suppressive properties of human CD4+CD25+ regulatory T?cells are dependent on CTLA-4 expression, European Journal of Immunology, vol.542, issue.12, pp.3485-3496, 2004.
DOI : 10.1002/eji.200324632

S. N. Snow and . Markovic, The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma, Leukemia, vol.18, pp.1085-1092, 2004.

F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia, Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature, vol.9, issue.6754, pp.708-712, 1999.
DOI : 10.1038/44385

A. Lanzavecchia and F. Sallusto, Dynamics of T Lymphocyte Responses: Intermediates, Effectors, and Memory Cells, Science, vol.290, issue.5489, pp.92-97, 2000.
DOI : 10.1126/science.290.5489.92

R. A. Seder and R. Ahmed, Similarities and differences in CD4+ and CD8+ effector and memory T cell generation, Nature Immunology, vol.4, issue.9, pp.835-842, 2003.
DOI : 10.1038/ni969

K. Tarte, G. Fiol, J. F. Rossi, and B. Klein, Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro, Leukemia, vol.14, issue.12, pp.2182-2192, 2000.
DOI : 10.1038/sj.leu.2401925

M. Jourdan, X. G. Zhang, M. Portier, J. M. Boiron, R. Bataille et al., IFN-alpha induces autocrine production of IL-6 in myeloma cell lines, J Immunol, vol.147, pp.4402-4407, 1991.

T. H. Alexander, G. M. Ortiz, M. F. Wellons, A. Allen, E. J. Grace et al., Changes in CD4+ T-Cell Differentiation Phenotype During Structured Treatment Interruption in Patients With Chronic HIV-1 Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.34, issue.5, pp.475-481, 2003.
DOI : 10.1097/00126334-200312150-00005

N. Rufer, A. Zippelius, P. Batard, M. J. Pittet, I. Kurth et al., Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions, Blood, vol.102, issue.5, pp.1779-1787, 2003.
DOI : 10.1182/blood-2003-02-0420

C. Baecher-allan, J. A. Brown, G. J. Freeman, and D. A. Hafler, CD4+CD25high Regulatory Cells in Human Peripheral Blood, The Journal of Immunology, vol.167, issue.3, pp.1245-1253, 2001.
DOI : 10.4049/jimmunol.167.3.1245

M. E. Lutsiak, R. T. Semnani, R. De-pascalis, S. V. Kashmiri, J. Schlom et al., Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide, Blood, vol.105, issue.7, pp.2862-2868, 2005.
DOI : 10.1182/blood-2004-06-2410

C. L. Mackall and R. E. Gress, Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy, Immunological Reviews, vol.152, issue.1, pp.61-72, 1997.
DOI : 10.1084/jem.181.3.993

S. S. Joshi, J. C. Lynch, S. Z. Pavletic, S. R. Tarantolo, S. J. Pirruccello et al., Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics, Blood, vol.98, issue.6, pp.1963-1970, 2001.
DOI : 10.1182/blood.V98.6.1963

E. Proietti, G. Greco, B. Garrone, S. Baccarini, C. Mauri et al., Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice., Journal of Clinical Investigation, vol.101, issue.2, pp.429-441, 1998.
DOI : 10.1172/JCI1348

A. M. Ercolini, B. H. Ladle, E. A. Manning, L. W. Pfannenstiel, T. D. Armstrong et al., T cells to the antitumor immune response, The Journal of Experimental Medicine, vol.12, issue.200, pp.1591-1602, 2005.
DOI : 10.1126/science.274.5284.94

J. Vela-ojeda, M. A. Esparza, E. Reyes-maldonado, L. Jimenez-zamudio, E. Garcia-latorre et al., Lymphocyte and Dendritic Cell Mobilization with Intermediate Doses of Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Donors, Stem Cells and Development, vol.14, issue.3, pp.310-316, 2005.
DOI : 10.1089/scd.2005.14.310

H. Kared, A. Masson, H. Adle-biassette, J. F. Bach, L. Chatenoud et al., Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nat Med, vol.54, issue.10, pp.78-84, 2004.

H. Y. Wang, D. A. Lee, G. Peng, Z. Guo, Y. Li et al., Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands, Immunity, vol.20, issue.1, pp.107-118, 2004.
DOI : 10.1016/S1074-7613(03)00359-5

T. Guillaume, D. B. Rubinstein, and M. Symann, Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation, Blood, vol.92, pp.1471-1490, 1998.

R. Setoguchi, S. Hori, T. Takahashi, and S. Sakaguchi, regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization, The Journal of Experimental Medicine, vol.136, issue.5, pp.723-735, 2005.
DOI : 10.1016/S1074-7613(00)80195-8

P. A. Antony and N. P. Restifo, CD4+CD25+ T Regulatory Cells, Immunotherapy of Cancer, and Interleukin-2, Journal of Immunotherapy, vol.28, issue.2, pp.120-128, 2005.
DOI : 10.1097/01.cji.0000155049.26787.45

O. Alpdogan, M. R. Van-den, and . Brink, IL-7 and IL-15: therapeutic cytokines for immunodeficiency, Trends in Immunology, vol.26, issue.1, pp.56-64, 2005.
DOI : 10.1016/j.it.2004.11.002

C. R. Ruprecht, M. Gattorno, F. Ferlito, A. Gregorio, A. Martini et al., regulatory T cells in inflamed synovia, The Journal of Experimental Medicine, vol.25, issue.11, pp.1793-1803, 2005.
DOI : 10.1182/blood-2002-08-2408

A. Trickett and Y. L. Kwan, T cell stimulation and expansion using anti-CD3/CD28 beads, Journal of Immunological Methods, vol.275, issue.1-2, pp.251-255, 2003.
DOI : 10.1016/S0022-1759(03)00010-3

D. J. Powell, L. L. Jr, S. A. Parker, and . Rosenberg, Large-Scale Depletion of CD25+ Regulatory T Cells from Patient Leukapheresis Samples, Journal of Immunotherapy, vol.28, issue.4, pp.403-411, 2005.
DOI : 10.1097/01.cji.0000170363.22585.5a

E. J. Shpall, The utilization of cytokines in stem cell mobilization strategies, Bone Marrow Transplantation, vol.23, issue.2, pp.13-19, 1999.
DOI : 10.1038/sj.bmt.1701669

V. Pigneux, P. Meresse, J. Clark, and . Reiffers, Stem cell factor in combination, 1999.